We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal court in Delaware has denied Baxalta’s request for a new trial in a suit brought by Bayer over patent infringement by Baxalta’s hemophilia A drug Adynovate. Read More
In a landmark ruling, a district judge in Oklahoma on Monday ordered Johnson and Johnson and its subsidiary Janssen to pay $572 million to the state for its role in the opioid epidemic. Read More
“Over the entire course of its review, the agency did not raise any issues suggesting non-approvability of golodirsen,” said Sarepta CEO Doug Ingram. Read More